Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-15 · accession 0001209191-21-070116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-16 | 2021-12-15 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +9,000 | 27.0K | +50% | +$4,770 |
| DMI | 2021-12-16 | 2021-12-09 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 187.9K | New | $0 |
| D | 2021-12-16 | 2021-12-15 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.00 | -9,000 | 432.6K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-15 | M | A | 9,000 | $0.53 | 26,970 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-09 | G | A | 40,000 | $0.00 | 40,000 | I See footnote | — | — | (F2) The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |
| 3 | Common | Common Stock | 2021-12-09 | G | D | 40,000 | $0.00 | 187,915 | I See footnote | — | — | (F1) The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |
| 4 | Derivative | Stock Option (right to buy) | 2021-12-15 | M | D | 9,000 | $0.00 | 432,574 | D | $0.53 · — to 2025-05-11 | 9,000 Common Stock | (F4) The shares subject to the option are fully vested and immediately exercisable. |